Attention Deficit/Hyperactivity Disorder
49
2
3
27
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.1%
3 terminated out of 49 trials
90.0%
+3.5% vs benchmark
33%
16 trials in Phase 3/4
30%
8 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (49)
A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)
A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.
Effect of Stimulant Medication on Loss of Control Eating in Youth With Attention Deficit/Hyperactivity Disorder
Effect of a Self-hypnosis on Attention Disorders and Anxiety in Children With Attention Deficit/Hyperactivity Disorder
A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
Pilot Testing PREschooler Care, Community Resources, Advocacy, Referral, Education (PRE-CARE)
An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD
Focus Groups in Ethnically and Racially Diverse Families
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
Oxytocin and Cognitive Control in Adult ADHD
Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children
A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medication in Adults With ADHD in the Primary Care Setting
Assesment of TDApp1 an eHelath Tool to Make Therapeutic Recommendations for Patients With ADHD
A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medications in Children With ADHD
Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders
An SMS Intervention to Improve Adherence to Stimulant Medications in Adults With ADHD
The Early Integrated Intervention for Child Brain-developmental Disorders in China
Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population
Real World Evidence of the Efficacy and Safety of FOQUEST
Structural and Functional Connectivity of Frontostriatal and Frontoparietal Networks as Endophenotypes of ADHD